Exploratory Study of the Digital Therapeutics CT-155 in the Treatment of People With Schizophrenia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05438160 |
|
Recruitment Status :
Completed
First Posted : June 29, 2022
Last Update Posted : August 22, 2022
|
Sponsor:
Click Therapeutics, Inc.
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
Click Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 31, 2022 |
| Actual Study Completion Date : | July 31, 2022 |